BIO-Key International Inc

Company Profile

BIO-Key International Inc had its IPO on 2002-02-21 under the ticker symbol BKYI.

The company operates in the Technology sector and COMPUTER COMMUNICATIONS EQUIPMENT industry. BIO-Key International Inc has a staff strength of 0 employees.

Stock update

Shares of BIO-Key International Inc opened at $1.59 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $1.59 - $1.6, and closed at $1.59.

This is a 0% increase from the previous day's closing price.

A total volume of 4,463 shares were traded at the close of the day’s session.

In the last one week, shares of BIO-Key International Inc have slipped by -20.5%.

BIO-Key International Inc's Key Ratios

BIO-Key International Inc has a market cap of $0.013 billion, indicating a price to book ratio of 1.005 and a price to sales ratio of 2.181.

In the last 12-months BIO-Key International Inc’s revenue was $0.006 billion with a gross profit of $0.003 billion and an EBITDA of $-0.005 billion. The EBITDA ratio measures BIO-Key International Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, BIO-Key International Inc’s operating margin was -90.8% while its return on assets stood at -18% with a return of equity of -35.9%.

In Q2, BIO-Key International Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 96.3%.

BIO-Key International Inc’s PE and PEG Ratio

Forward PE

-

Trailing PE

-

PEG

0

Its diluted EPS in the last 12-months stands at $-0.667 per share while it has a forward price to earnings multiple of - and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into BIO-Key International Inc’s profitability.

BIO-Key International Inc stock is trading at a EV to sales ratio of 1.554 and a EV to EBITDA ratio of -1.804. Its price to sales ratio in the trailing 12-months stood at 2.181.

BIO-Key International Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$0.000 billion

Total Liabilities

$0.000 billion

Operating Cash Flow

$0.000 billion

Capital Expenditure

$0.000 billion

Dividend Payout Ratio

0%

BIO-Key International Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

BIO-Key International Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

BIO-Key International Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, BIO-Key International Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, BIO-Key International Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price

$1.59

52-Week High

$3.21

52-Week Low

$1.45

Analyst Target Price

$4

BIO-Key International Inc stock is currently trading at $1.59 per share. It touched a 52-week high of $3.21 and a 52-week low of $3.21. Analysts tracking the stock have a 12-month average target price of $4.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.